Drugs / Sangstat
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00029380 Background | Jan 1999 → Aug 2006 | beta thalassemia, sickle cell disease | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sangstat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00029380 ↗ |
| Modality | Protein / enzyme biologic | “rabbit anti-thymocyte globulin (Sangstat)” NCT00029380 ↗ |